GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Ending Cash Position

Arctic Bioscience AS (OSL:ABS) Ending Cash Position : kr19.83 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Ending Cash Position?

Arctic Bioscience AS's Ending Cash Position for the quarter that ended in Jun. 2024 was kr19.83 Mil.

Arctic Bioscience AS's quarterly Ending Cash Position declined from Jun. 2023 (kr113.81 Mil) to Dec. 2023 (kr79.60 Mil) and declined from Dec. 2023 (kr79.60 Mil) to Jun. 2024 (kr19.83 Mil).

Arctic Bioscience AS's annual Ending Cash Position declined from Dec. 2021 (kr227.36 Mil) to Dec. 2022 (kr144.15 Mil) and declined from Dec. 2022 (kr144.15 Mil) to Dec. 2023 (kr79.60 Mil).

Arctic Bioscience AS Ending Cash Position Historical Data

The historical data trend for Arctic Bioscience AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Ending Cash Position Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial - 12.60 227.36 144.15 79.60

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 177.77 144.15 113.81 79.60 19.83

Arctic Bioscience AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Arctic Bioscience AS's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=144.151+-64.549
=79.60

Arctic Bioscience AS's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=79.602+-59.771
=19.83

Arctic Bioscience AS Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Ending Cash Position
Comparable Companies
OSL:PCIB OSL:CRNA OSL:SOFTX OSL:ULTI OSL:ABTEC OSL:EXTX VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE UTHR MRNA NEUP SMMT
Traded in Other Exchanges
N/A
Address
Industrivegen 42, Orsta, NOR, 6155
Website
https://www.arctic-bioscience.com
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines